Document is current
Any future updates will be listed below
-
Authors
Baljevic, Muhamed https://orcid.org/0000-0002-0630-8458
Sborov, Douglas W.
Kumar, Shaji K. https://orcid.org/0000-0001-5392-9284
- License Information
-
More Information
Article History
Received: 19 May 2024
Revised: 9 July 2024
Accepted: 10 July 2024
First Online: 17 July 2024
Competing interests
: Muhamed Baljevic: Consultancy: AbbVie, Pfizer. Advisory Boards: Janssen Biotech, BMS/Celgene, Sanofi-Genzyme. IRCs: Parexel. Douglas W Sborov: Consultancy/Advisory: GlaxoSmithKline, Janssen, Sanofi, Abbvie, Bristol Myer Squibb, Pfizer, Bioline, Arcellx, AstraZeneca, Genentech. IRC: Parexel. Shaji K Kumar: nothing to declare.
